Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB-WT) Income from Continuing Operations (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Income from Continuing Operations for 3 consecutive years, with 36592000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 25.99% to 36592000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 204627000.0 through Dec 2025, up 63.97% year-over-year, with the annual reading at 204627000.0 for FY2025, 63.97% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 36592000.0 at Nuvation Bio, up from 55792000.0 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 13787000.0 in Q4 2023, with the low at 462492000.0 in Q2 2024.
  • Average Income from Continuing Operations over 3 years is 70697333.33, with a median of 38901000.0 recorded in 2024.
  • The sharpest move saw Income from Continuing Operations crashed 2140.76% in 2024, then surged 87.24% in 2025.
  • Over 3 years, Income from Continuing Operations stood at 13787000.0 in 2023, then tumbled by 258.63% to 49445000.0 in 2024, then increased by 25.99% to 36592000.0 in 2025.
  • According to Business Quant data, Income from Continuing Operations over the past three periods came in at 36592000.0, 55792000.0, and 59007000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.